Research Projects & Studies

Investigational Products, Systems and Devices
Pima Heart and Vascular physicians are committed to finding new and innovative treatments that will help improve the quality of life for people with cardiovascular and venous disease. Highly regarded as leaders in their field, they are invited as key speakers for medical conferences and continuing medical education meetings across the world.

As new treatments, systems and devices are developed, several of the largest companies who develop these new technologies look to our physicians for testing and evaluation. Pima Heart and Vascular surgeons have played a role in some of the most exciting breakthroughs over the past several years.

AMPLATZER PFO Occluder Post Approval Study (PFO PAS)
The purpose of this single-arm, multi-center study is to confirm the safety and effectiveness of the AMPLATZER™ PFO Occluder in the post Approval Setting.

Sponsor: Abbott
Principal Investigator: Dr. Waggoner
Sub Investigators: Drs. Gheewala and Thomas

Public Link

Restore EF
Aims to replicate real-world evidence and prior clinical investigations to demonstrate the long-term benefits of Protected PCI on LVEF and patient quality of life.

Sponsor: ABIOMED
Principal Investigator: Dr. Waggoner

PROTECTED TAVR
To demonstrate that use of the Sentinel® Cerebral Protection System significantly reduces the risk of peri-procedural stroke (≤72 hours) after transcatheter aortic valve replacement (TAVR).

Principal Investigator: Dr. Waggoner
Sub Investigators: Drs. Gheewala and Thomas

Public Link 

Assessing the Role of Pressure Recovery in Determining Elevated Transvalvular Gradients by Echocardiography Following TAVR for Native Aortic Stenosis and ViV Degenerated Bioprosthetic Valves: A Retrospective Study

Multicenter collaboration led by Beaumont William Hospital
Principal Investigator: Dr. Waggoner